Business
Press Release Jan 04 2021
Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 03, 2021, titled "Zydus Cadila receives approvals from the DCGI to start Phase Ill Clinical Trial of ZyCoV-D- fully indigenously developed vaccine".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 03, 2021, titled \"Zydus Cadila receives approvals from the DCGI to start Phase Ill Clinical Trial of ZyCoV-D- fully indigenously developed vaccine\". View Attachment","length":395,"tagName":"div"}]